Cargando…
Comparing long-term value creation after biotech and non-biotech IPOs, 1997–2016
We compared the financial performance of 319 BIOTECH companies focused on developing therapeutics with IPOs from 1997–2016, to that of paired, non-biotech CONTROL companies with concurrent IPO dates. BIOTECH companies had a distinctly different financial structure with high R&D expense, little r...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7787373/ https://www.ncbi.nlm.nih.gov/pubmed/33406113 http://dx.doi.org/10.1371/journal.pone.0243813 |